Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing ...

During a live event, Alexander I. Spira, MD, PhD, and participants NGS testing practices and the rationale behind their ...

The NHS trust says the software will improve the efficiency and accuracy of chest X-ray analysis ... that could speed up the detection of lung cancer and other serious illnesses.

AstraZeneca, a global, science-led biopharmaceutical company, announced that its Imfinzi (durvalumab) has been recommended for approval in the European Union (EU) as monotherapy for the treatment of ...

Novel therapies targeting molecular pathways, including DLL3 and PARP inhibitors, show promise in improving SCLC survival outcomes. Tarlatamab, a DLL3-targeting bispecific T-cell engager, achieved ...

are associated with improved long-term survival compared to wedge resection for patients with early-stage non-small cell lung cancer (NSCLC). The study analyzed outcomes for more than 32,000 stage ...

A new laser is helping doctors detect lung cancer ... lung cancer with a blue laser light in what may become a routine screening programme. Current diagnostic procedures include chest X-rays ...

Expert Rev Mol Diagn. 2010;10(6):799-815. Multidetector CT as a screening tool for early lung cancer detection is being evaluated in large ongoing trials, in the USA (NLST) and in Europe (NELSON ...

The findings could help explain why some cancer treatments, like immunotherapy, are effective for some patients but not others. Clinical specimens from melanoma and non-small-cell lung cancer ...